Improved cytosolic translocation and tumor-killing activity of Tat-shepherdin conjugates mediated by co-treatment with Tat-fused endosome-disruptive HA2 peptide
Authors:
- Tomoaki YoshikawaTYTomoaki Yoshikawa
- Yohei MukaiYMYohei Mukai
- Natsue YamanadaNYNatsue Yamanada
- Sunao ImaiSISunao Imai
- Kazuya NaganoKNKazuya Nagano
- Yasunobu YoshidaYYYasunobu Yoshida
- Hiroko ShibataHSHiroko Shibata
- Yasuo YoshiokaYYYasuo Yoshioka
- Shinsaku NakagawaSNShinsaku Nakagawa
- Haruhiko KamadaHKHaruhiko Kamada
- Shin-Ichi TsunodaSTShin-Ichi Tsunoda
- 1 November 2007
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 363 (4) , 1027-1032
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Combination treatment with Grb7 peptide and Doxorubicin or Trastuzumab (Herceptin) results in cooperative cell growth inhibition in breast cancer cellsBritish Journal of Cancer, 2007
- Survivin: A promising tumor biomarkerCancer Letters, 2007
- The taming of the cell penetrating domain of the HIV Tat: Myths and realitiesJournal of Controlled Release, 2007
- A Human Protein-Protein Interaction Network: A Resource for Annotating the ProteomeCell, 2005
- Genome‐wide screening for gene function using RNAi in mammalian cellsImmunology & Cell Biology, 2005
- Survivin as a target for new anticancer interventionsJournal of Cellular and Molecular Medicine, 2005
- Survivin and p53 Modulate Quercetin-induced Cell Growth Inhibition and Apoptosis in Human Lung Carcinoma CellsJournal of Biological Chemistry, 2004
- Adenovirus-Mediated Transfer of siRNA against Survivin Induced Apoptosis and Attenuated Tumor Cell Growth in Vitro and in VivoMolecular Therapy, 2004
- Influenza fusion peptidesBiochemical Society Transactions, 2001
- In Vivo Protein Transduction: Delivery of a Biologically Active Protein into the MouseScience, 1999